PatientCrossroads and Informedika Announce Strategic Partnership to Integrate Lab Results and Rx Data into CONNECT Open Patient Registry

Integration Makes it Easier for Patients to Share Their Data With Medical Researchers to Better Understand Disease Progression.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Informedika operates between physicians and testing labs, and PatientCrossroads acts between patients and researchers. Combining our two networks would be like interlocking rings, extending the reach and effectiveness of both.

SAN MATEO, CA (PRWEB) April 23, 2013

PatientCrossroads and Informedika today announced a strategic partnership in which they will explore the automated inclusion of patients’ laboratory test results and prescription information with PatientCrossroads patient registries.

The combination of Informedika’s data - lab results and medication history - with PatientCrossroads’ CONNECT open-access patient registry would make it easier for patients to more easily provide detailed disease-related information about their conditions. The combination of patient provided data with lab and medication history would enable a more complete picture of disease to help medical researchers working to find causes and treatments, and pharmaceutical companies developing new diagnostics and medications.

“Informedika is the leading aggregator of diagnostic and prescription data, streamlining and simplifying interactions between physicians and testing labs,” said Kyle Brown, founder of PatientCrossroads. “Tapping into the natural workflow of physicians via Informedika would allow the CONNECT registry to include richer data, leading to a more complete understanding of diseases and conditions. Informedika complements PatientCrossroads’ conviction that medical advances are made when results are shared, when information is collected in a standardized way, and when patients remain firmly at the center of the process.”

“As a trusted, third-party gatekeeper of de-identified patient provided medical history, PatientCrossroads plays an important role in understanding disease natural history,” said Steven Yaskin, founder and CEO of Informedika. “Informedika operates between physicians and testing labs, and PatientCrossroads acts between patients and researchers. Combining our two networks would be like interlocking rings, extending the reach and effectiveness of both.”

The PatientCrossroads CONNECT Registry Program is a shared, open-access patient registry able to collect data on any disease, from the most rare to more common diseases. In CONNECT, patients control their data, opting in and consenting to share their de-identified information. PatientCrossroads is responsible for ensuring physicians and clinicians, medical researchers, pharmaceutical companies and disease foundations all have equal and equitable access to the de-identified patient information.

The Informedika Network provides true bi-directionality for both requisitioning and processing diagnostic results, medical supplies ordering and mHealth device provisioning. Informedika offers diagnostic data ordering and results from any lab in US including phlebotomy, pathology, genetics, and radiology as well as Rx, wheel chairs etc. DME, mHealth devices, and most kinds of information not typically available in EMR products today in "one pane of glass." Informedika provides this 360-degree view of the patient free to physicians and other authorized clinicians.

About Informedika

Informedika is revolutionizing the clunky, costly and error-prone process of lab test ordering – replacing the phone and fax with a nationwide E-Requisition network that connects doctors to diagnostic testing service providers. Informedika streamlines orders, cuts costs, improves accuracy, increases quality of care and provides real-time access to results. For more information about the Informedika E-Requisition Network, visit http://www.informedika.com.

About PatientCrossroads

PatientCrossroads provides registry systems that connect disease communities with scientists studying those conditions. Offering software, technology, management and data curation services, PatientCrossroads registries collect data on more than 250 rare diseases and power the NIH’s Global Rare Diseases (Patient) Registry and Data Repository (GRDR) and the NIH NICHD Down Syndrome registry. PatientCrossroads is a full partner in Europe’s RD-Connect platform ensuring global, open access to patient-provided medical histories. For more information, visit http://www.patientcrossroads.com.


Contact

Follow us on: Contact's Twitter